Form 4 for MGNX MACROGENICS INC
Accepted 2022-11-25 00:00:00 ET · period of report 2022-11-22 · accession 0000899243-22-036996 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-25 | 2022-11-22 | MGNX | BIOTECH TARGET N V | 10% | P - Purchase | $5.96 | +300.0K | 8.53M | +4% | +$1.79M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-22 | P | A | 300,000 | $5.96 | 8,529,963 | D | — | — |